狂犬病疫苗(Vero细胞)(吉林迈丰生物药业有限公司)(Rabies Vaccine (Vero Cell)(Jilin Mai Fung Bio-Pharmaceutical Co Ltd))

概要

基本信息

药物类型

预防性疫苗

别名-

靶点-

作用机制

免疫刺激剂

治疗领域

感染其他疾病

在研适应症

狂犬病

非在研适应症-

原研机构

吉林惠康生物药业有限公司

在研机构

吉林惠康生物药业有限公司

非在研机构-

最高研发阶段批准上市

首次获批日期

中国 (2006-11-22),

狂犬病

最高研发阶段(中国)批准上市

特殊审评-

登录后查看时间轴

关联

3

项与狂犬病疫苗(Vero细胞)(吉林迈丰生物药业有限公司) 相关的临床试验

NCT06548139 / Not yet recruiting临床2期

Multicenter, Randomized, Double-blind, Positive Control Evaluation of Rabies Monomab CBB 1 Combination Vaccine for Antibody Neutralization Activity and Safety Phase Clinical Trials in Healthy People

To evaluate the antibody neutralization activity and safety of rabies mAb CBB 1 combination vaccine used in healthy people

开始日期2024-07-31

申办/合作机构

长春百克生物科技股份公司

NCT05832073 / Not yet recruiting早期临床1期

Multicenter, Randomized, Double-blind, Placebo / Positive Control Evaluation of the First Safety, Pharmacokinetic and Pharmacodynamic Phase I Clinical Trial of Rabies Monomab CBB 1 in Healthy People

rabies mab CBB 1 is mainly used for passive immunization of patients bitten or scratched by rabies or other animals carrying rabies virus, this study mainly studies the safety, tolerability, pharmacokinetics, neutralizing antibody activity and immunogenic characteristics of rabies mAb CBB 1 in healthy adults

开始日期2023-04-30

申办/合作机构

长春百克生物科技股份公司